Trials / Completed
CompletedNCT01304706
Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Alimera Sciences · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will assess the safety and utility of the new inserter for the administration of ILUVIEN in subjects with diabetic macular edema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluocinolone Acetonide | 0.2 μg/day |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2013-11-01
- First posted
- 2011-02-25
- Last updated
- 2015-05-04
- Results posted
- 2015-05-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01304706. Inclusion in this directory is not an endorsement.